[{"Assets_0_Q1_USD":825160000.0,"CommonStockSharesOutstanding_0_Q1_shares":51633991.0,"EarningsPerShareBasic_1_Q1_USD":0.51,"EarningsPerShareDiluted_1_Q1_USD":0.49,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":27133000.0,"NetIncomeLoss_1_Q1_USD":26352000.0,"StockholdersEquity_0_Q1_USD":351869000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":53788346.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":51536474.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS INC","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180510"}]